ESP & Manufacturer Restrictions
We provide oversight of 340B ESP and manufacturer restrictions with analytics, impact reporting, data submission, pricing reviews, and claim resolution to ensure compliance and profitability. Our team manages designations, incomplete claims, and HIN support so you can confidently navigate manufacturer requirements.
Questions? You’re covered.
We provide complete oversight of 340B ESP, including data submission management, pricing reviews, and manufacturer designations to ensure compliance. Our analytics, such as Manufacturer Impact Reports and Profitability by Pharmacy, deliver clear insights into how restrictions impact your program and highlight where adjustments may be needed.
As a HIBCC Licensee, we provide hospitals with HIN support to ensure smooth data exchange and accurate manufacturer reporting. This streamlines compliance reduces administrative burden and keeps your program running efficiently.
Turning ESP Data Challenges Into $1.2M in Annual Program Savings
Montana Hospital was experiencing negative program performance, with approximately $14,000 in annual losses driven by administrative burden and challenges related to ESP data submission requirements and manufacturer eligibility tracking.
The Challenge
The hospital’s 340B program was not generating sufficient savings to offset operational costs. Key barriers included:
- Complex ESP data submission requirements
- Difficulty maintaining consistent manufacturer eligibility compliance
- Limited internal bandwidth to manage ongoing administrative demands
These issues contributed to underperformance across the program and reduced overall financial benefit.
Our Approach
ACI stepped in to manage and streamline the hospital’s ESP data submission and ongoing program administration. This included:
- Oversight and execution of ESP data submission processes
- Support in maintaining manufacturer eligibility alignment
- Reduction of internal administrative workload through centralized management
The Outcome
Within one year of implementation, Montana Hospital’s program performance shifted significantly:
- Improved from ($14,000) annual loss
- To approximately $1.2M in annual savings (2025)
By addressing ESP management and reducing administrative strain, the hospital was able to fully realize the financial potential of its 340B program.
Subscribe
Subscribe to our newsletter for updates
"*" indicates required fields